Related Experiment Video
Updated: Jun 10, 2026

06:10
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
Lysosomal targeting and genetic/DNA vaccines development
1Department of Neurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Discovery Medicine
|August 14, 2010
Summary
DNA vaccines represent a novel approach, utilizing genetic material to stimulate protective immunity against pathogens. This innovative vaccine technology bypasses traditional methods by directly instructing cells to produce immunogens.
Area of Science:
- Immunology
- Vaccinology
- Molecular Biology
Background:
- Antigen presentation via MHC class I and II molecules is crucial for adaptive immunity.
- CD4+ T cells recognize antigens complexed with MHC II, driving humoral and cell-mediated responses.
- CD8+ cytotoxic T cells recognize antigens complexed with MHC I, eliminating infected cells.
Purpose of the Study:
- To introduce the concept and mechanism of DNA vaccines as a new generation of vaccine technology.
- To explain how DNA vaccines differ from traditional vaccine platforms.
- To elucidate the process by which DNA vaccines elicit protective immunity.
Main Methods:
- Delivery of a gene encoding a specific immunogen into host cells.
- Internal translation of the delivered gene into the target immunogen within the host.
- Induction of an immune response against the internally produced immunogen.
Main Results:
- DNA vaccines provide a method for in vivo production of antigens.
- The internally generated antigens can stimulate both CD4+ and CD8+ T cell responses.
- This leads to the potential for robust protective immunity against various pathogens and diseases.
Conclusions:
- DNA vaccines offer a promising alternative to conventional vaccines.
- This technology leverages the host's cellular machinery for antigen production.
- DNA vaccines have the potential to induce comprehensive protective immunity.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
In-vitro Mutagenesis
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

